Mumps Vaccine (MumpsVax) Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

What Are the Market Size and Growth Forecast for the Mumps Vaccine (MumpsVax) Market?
In recent times, the market for the mumps vaccine, mumpsvax, has significantly expanded. The market is projected to grow from a value of $2,057.93 million in 2024 to $2,210.59 million in 2025, translating to a compound annual growth rate (CAGR) of 7.4%. The upward trend during the historical period can be credited to higher rates of vaccinations amongst children, a surge in global health initiatives, greater public confidence in vaccines, heightened travel cognizance, and an upsurge in immunization drives.

There is an anticipated significant increase in the mumps vaccine (mumpsvax) market size in the coming years. The projected growth is estimated to reach $2,902.21 million in 2029 with a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is primarily due to factors such as increased incidences of diseases preventable by vaccines, heightened awareness about adult vaccination, growing health consciousness, expansion of immunization programs, and greater international health efforts. The forecast period is likely to see key trends such as personalized vaccination plans, incorporation of digital health, improved surveillance systems, research and development in adult vaccination, and the inclusion of artificial intelligence.

What Is Contributing to the Growth of the Mumps Vaccine (MumpsVax) Market?
The growing incidence of infectious diseases is anticipated to fuel the mumps vaccine (mumpsvax) market's expansion. Infectious diseases, caused by harmful microorganisms such as viruses, bacteria, fungi or parasites, can be spread person to person or via polluted surroundings. Factors like urbanization, climate alteration, globalization and shifts in human demographics and behavior that enhance the transmission of pathogens primarily drive their prevalence. Mumpsvax, a vaccine against mumps infection (an infectious disease caused by mumps virus), is usually included in the MMR (measles, mumps, rubella) immunization. For instance, as per a report by the UK Health Security Agency in 2024, during 2023, the West Midlands region reported the highest measles cases, recording 160 (44%), trailed by London with 122 (33%). Importantly, children aged 10 or under composed 63% of the total cases, reaching 232 cases. There was a noticeable increase in measles activity towards the year's close, with 157 new cases marked in December, contrasting with just 45 cases in November. Hence, increasing infectious diseases prevalence is propelling the mumps vaccine (mumpsvax) market. An Expected Surge In Healthcare Spending To Improve Mumpsvax Accessibility And Vaccination Rates

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19909&type=smp

Which Key Market Leaders Are Driving Mumps Vaccine (MumpsVax) Industry Growth?
Major companies operating in the mumps vaccine (mumpsvax) market include Merck & Co. Inc., GlaxoSmithKline plc

What Are the Main Segments in the Mumps Vaccine (MumpsVax) Market?
The mumps vaccine (mumpsvax)market covered in this report is segmented -

1) By Product Type: Monovalent; Combinational; Divalent; Trivalent; Other Product Types
2) By Age Group: Pediatric; Adult
3) By Distribution Channels: Hospital pharmacies; Drug Stores; Retail Pharmacies
4) By End-User: Pediatric Clinic; Hospitals; Non-Governmental Organization (NGOs); Other End-Users

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/mumps-vaccine-mumpsvax-global-market-report

Which Geographic Area Leads the Mumps Vaccine (MumpsVax) Market?
North America was the largest region in the mumps vaccine (mumpsvax) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mumps vaccine (mumpsvax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Mumps Vaccine (MumpsVax) Global Market Report?

- Market Size Analysis: Analyze the mumps vaccine (mumpsvax) Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the mumps vaccine (mumpsvax) market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall mumps vaccine (mumpsvax) market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the mumps vaccine (mumpsvax) market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19909

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.